# Nutrien Ltd.: financial statements, quarterly

NTR · NYSE · CIK 1725964 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ntr.md) · [Financials](/companies/ntr/financials.md) · [Filings](/companies/ntr/filings.md) · [Insiders](/companies/ntr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ntr/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2016-12-31) | period not labelled (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0001193125-19-053855.md) | [0.1](/filings/0001193125-20-055383.md) | [2.3](/filings/0001193125-21-059301.md) | [0.7](/filings/0001193125-22-053904.md) | [1.5](/filings/0001193125-23-048055.md) | [0.5](/filings/0001193125-24-055096.md) | [0.9](/filings/0001193125-25-041502.md) | [0.9](/filings/0001193125-26-081326.md) | [0.9](/filings/0001193125-26-081326.md) | [0.7](/filings/0001193125-26-081326.md) |
| Current assets | $bn | not reported | [3.3](/filings/0001193125-19-053855.md) | [11.7](/filings/0001193125-20-055383.md) | [10.7](/filings/0001193125-21-059301.md) | [11.5](/filings/0001193125-22-053904.md) | [13.8](/filings/0001193125-23-048055.md) | [16.3](/filings/0001193125-24-055096.md) | [14.2](/filings/0001193125-25-041502.md) | [13.8](/filings/0001193125-26-081326.md) | [14.7](/filings/0001193125-26-081326.md) |
| Total assets | $bn | not reported | [17.0](/filings/0001193125-19-053855.md) | [45.5](/filings/0001193125-20-055383.md) | [46.8](/filings/0001193125-21-059301.md) | [47.2](/filings/0001193125-22-053904.md) | [50.0](/filings/0001193125-23-048055.md) | [54.6](/filings/0001193125-24-055096.md) | [52.7](/filings/0001193125-25-041502.md) | [51.8](/filings/0001193125-26-081326.md) | [52.3](/filings/0001193125-26-081326.md) |
| Current liabilities | $bn | not reported | [1.6](/filings/0001193125-19-053855.md) | [8.3](/filings/0001193125-20-055383.md) | [9.1](/filings/0001193125-21-059301.md) | [8.5](/filings/0001193125-22-053904.md) | [12.4](/filings/0001193125-23-048055.md) | [14.3](/filings/0001193125-24-055096.md) | [12.1](/filings/0001193125-25-041502.md) | [12.0](/filings/0001193125-26-081326.md) | [11.0](/filings/0001193125-26-081326.md) |
| Total liabilities | $bn | not reported | [8.7](/filings/0001193125-19-053855.md) | [21.1](/filings/0001193125-20-055383.md) | [23.9](/filings/0001193125-21-059301.md) | [24.8](/filings/0001193125-22-053904.md) | [26.3](/filings/0001193125-23-048055.md) | [28.7](/filings/0001193125-24-055096.md) | [27.5](/filings/0001193125-25-041502.md) | [27.4](/filings/0001193125-26-081326.md) | [26.9](/filings/0001193125-26-081326.md) |
| Shareholders' equity | $bn | [8.2](/filings/0001193125-19-053855.md) | [8.3](/filings/0001193125-20-055383.md) | [24.4](/filings/0001193125-21-059301.md) | [22.9](/filings/0001193125-22-053904.md) | [22.4](/filings/0001193125-22-053904.md) | [23.7](/filings/0001193125-23-048055.md) | [25.8](/filings/0001193125-24-055096.md) | [25.2](/filings/0001193125-25-041502.md) | [24.4](/filings/0001193125-26-081326.md) | [25.3](/filings/0001193125-26-081326.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 569,260,406 at 2020-12-31, from the cover of the [40-F filed 2021-02-26](/filings/0001193125-21-059301.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.